[ad_1]
LONDON, January 26, 2023 (GLOBE NEWSWIRE) — roots analysis announced the addition ofmRNA synthesis and mRNA manufacturing services Markets (2nd Edition), 2022-2035” report to the list of offerings.
With the recent success and expansion of the pipeline of mRNA-based products in the market, mRNA as a therapeutic agent has received a great deal of attention from the medical community. However, challenges such as high capital requirements, stringent regulations, and a lack of technical expertise have made outsourcing the preferred business model, prompting CMOs to upgrade their existing capabilities and service portfolios to meet the growing demand for mRNA-based products. Compatible with
To order this 160+ page report with over 100 figures and 90+ tables, please visit:
https://www.rootsanalysis.com/reports/mrna-synthesis-and-manufacturing-market.html
Key market insights
Today, more than 30 companies worldwide claim to offer custom mRNA synthesis services.
The majority of service providers are medium-sized players (44%), followed by small (35%), large (12%) and very large (9%) players. Additionally, more than 25% of his stakeholders have been established since his 2010. It’s also worth mentioning that over 50% of all his players are based in North America, especially the US.
More than 40 companies worldwide claim to offer contract mRNA manufacturing and mRNA filling/finishing services for mRNA vaccines and mRNA therapeutics.
Of the aforementioned players, nearly 85% of contract manufacturing service providers are based in North America and Europe. In particular, more than 50% of all players engaged in this sector provide services for active pharmaceutical ingredient (API) manufacturing.
There are currently over 95 mRNA synthesis kits available on the market.
Nearly 70% of mRNA synthesis kits contain a capping enzyme. 96% of these use the T7 RNA polymerase enzyme mix for synthesis of modified mRNA. It’s worth highlighting that the majority of kit developers (54%) are small players.
Over 170 clinical trials are registered worldwide to evaluate mRNA therapeutics and mRNA vaccines
Clinical research activity is reported to have increased at a steady CAGR of 44% between 2017 and 2022 in terms of the number of trials enrolled. Of the total number of trials enrolled, nearly 22% have already completed and 46% of trials are actively recruiting participants.
Partnership activity within this domain grew at a CAGR of 60% between 2019 and 2022
About 34% of deals closed in 2021. The majority of instances captured in the report are manufacturing contracts, making up his 22% of total partnerships. Additionally, most of the intercontinental deals are tied by players based in North America.
North America and Europe are expected to capture nearly 65% of the global market share by 2035.
The Asia-Pacific market is likely to grow at the highest CAGR between 2022 and 2035. In terms of product types, active pharmaceutical ingredients (APIs) are expected to hold a larger share (70%) of the total mRNA synthesis and manufacturing services market in 2035.
To request a sample copy/brochure of this report, please visit:
https://www.rootsanalysis.com/reports/mrna-synthesis-and-manufacturing-market/request-sample.html
Answers to key questions
- What are the factors driving the mRNA synthesis and mRNA manufacturing market?
- How many companies offer custom mRNA synthesis services?
- How many companies offer contract mRNA manufacturing services for commercial purposes?
- How many kits for mRNA synthesis are on the market?
- Which geographic segments will have the highest growth rates in the mRNA synthesis and manufacturing market?
- Which segment accounts for the largest mRNA synthesis and mRNA manufacturing market share in terms of product type?
- What are the trends in partnerships and collaborations in the area of mRNA synthesis and manufacturing?
- Who Are the Key Players in This mRNA Synthesis and mRNA Manufacturing Market?
The economic opportunities in the mRNA synthesis and manufacturing services market are analyzed across the following segments:
Product type
- Active pharmaceutical ingredient (API)
- Pharmaceuticals (FDF)
Application area
- mRNA vaccine
- mRNA therapeutics
therapeutic area
- Infection
- neoplastic disease
- Other diseases
Main geographical area
- North America
- Europe
- Asia Pacific
- latin america
- Middle East and North Africa
- rest of the world
The study also includes detailed profiles of key players (as follows) engaged in the mRNA synthesis and manufacturing domains. Each profile includes a brief overview of the company, details on its service portfolio (for mRNA synthesis and contract manufacturing service providers) / product portfolio (for mRNA synthesis kit providers), recent developments, and an informed outlook for the future. is included.
- Aldebron
- APExBIO
- biomay
- biosynthesis
- cell script
- eTheRNA
- Eurogentec
- Jena Biosciences
- new england bio lab
- thermo fisher scientific
- Trilink Biotechnologies
For more information, please visit:
https://www.rootsanalysis.com/reports/mrna-synthesis-and-manufacturing-market.html or email sales@rootsanalysis.com
You may also be interested in the following titles:
- mRNA therapeutic drug and mRNA vaccine market: Global Trends and Industry Analysis, 2022-2035
- Biopharmaceutical contract manufacturing market: Industry Trends and Global Forecasts, 2022-2035
- ADC Contract Manufacturing Market (5th Edition): Industry Trends and Global Forecasts, 2022-2035
- Continuous Manufacturing (Small Molecule and Biologics) Market (Second Edition): Industry Trends and Global Forecasts, 2022-2035
- Peptide Therapeutics: The Contract API Manufacturing Market: Industry Trends and Global Forecasts, 2022-2035
[ad_2]
Source link
